Effects of interferons and cytokines on melanoma cellsGARBE, C; KRASAGAKIS, K.Journal of investigative dermatology. 1993, Vol 100, Num 2, pp 239S-244S, issn 0022-202X, SUPArticle

Erythema annulare centrifugum and osteoarthritis treated with hyaluronic acidIOANNIDOU, D; KRASAGAKIS, K; STEFANIDOU, M et al.Clinical and experimental dermatology (Print). 2002, Vol 27, Num 8, pp 720-722, issn 0307-6938, 3 p.Article

Cutaneous metastatic angiosarcoma with a lethal outcome, following radiotherapy for a cervical carcinomaKRASAGAKIS, K; HETTMANNSPERGER, U; TEBBE, B et al.British journal of dermatology (1951). 1995, Vol 133, Num 4, pp 610-614, issn 0007-0963Article

Perifollicular fibromasKRASAGAKIS, K; BLUME-PEYTAVI, U; GOERDT, S et al.EJD. European journal of dermatology. 1996, Vol 6, Num 5, pp 387-388, issn 1167-1122Article

Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-α on sensitive human melanoma cells in vitro may result in selection of cells in vitro may results in selection of cells with enhanced markers of malignancyZOUBOULIS, C. C; SCHROÊDER, K; GARBE, C et al.Journal of investigative dermatology. 1990, Vol 95, Num 6, pp S223-S230, issn 0022-202X, SUPConference Paper

Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitroEBERLE, J; KRASAGAKIS, K; ORFANOS, C. E et al.International journal of cancer. 1997, Vol 71, Num 3, pp 396-401, issn 0020-7136Article

Local complications of erysipelas: a study of associated risk factorsKRASAGAKIS, K; SAMONIS, G; VALACHIS, A et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 4, pp 351-354, issn 0307-6938, 4 p.Article

The role of endothelial cell apoptosis in the effect of etanercept in psoriasisAVRAMIDIS, G; KRUGER-KRASAGAKIS, S; KRASAGAKIS, K et al.British journal of dermatology (1951). 2010, Vol 163, Num 5, pp 928-934, issn 0007-0963, 7 p.Article

Management of severe scleroderma with long-term extracorporeal photopheresisKRASAGAKIS, K; DIPPEL, E; RAMAKER, J et al.Dermatology (Basel). 1998, Vol 196, Num 3, pp 309-315, issn 1018-8665Article

Remission of scleromyxoedema following treatment with extracorporeal photopheresisKRASAGAKIS, K; ZOUBOULIS, C. C; OWSIANOWSKI, M et al.British journal of dermatology (1951). 1996, Vol 135, Num 3, pp 463-466, issn 0007-0963Article

RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood : Evaluation strategy and correlation with known prognostic markers in 123 melanoma patientsFARTHMANN, B; EBERLE, J; KRASAGAKIS, K et al.Journal of investigative dermatology. 1998, Vol 110, Num 3, pp 263-267, issn 0022-202XArticle

Psoriatische Onycho-Pachydermo-Periostitis (POPP) = Psoriatia onycho-pachydermo-periostitis (POPP)SCHRÖDER, K; GOERDT, S; SIEPER, J et al.Hautarzt. 1997, Vol 48, Num 7, pp 500-503, issn 0017-8470Article

Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitroKRASAGAKIS, K; GARBE, C; EBERLE, J et al.Archives of dermatological research (Print). 1995, Vol 287, Num 3-4, pp 259-265, issn 0340-3696Conference Paper

Calcium/calmodulin stimulation of human melanoma cell growth and differentiation in vitroHENKEL, U; WOLLINA, U; GARBE, C et al.EJD. European journal of dermatology. 1992, Vol 2, Num 4, pp 273-278Article

12-O-tetradecanoylphorbol-13-acetate not only modulates proliferation rates, but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitroKRASAGAKIS, K; GARBE, C; KRÜGER-KRASAGAKES, S et al.Journal of investigative dermatology. 1993, Vol 100, Num 5, pp 653-659, issn 0022-202XArticle

Effects of interferon on cultured human melanocytes in vitro : interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenocyteKRASAGAKIS, K; GARBE, C; KRÜGER, S et al.Journal of investigative dermatology. 1991, Vol 97, Num 2, pp 364-372, issn 0022-202XArticle

Early development of multiple epithelial neoplasms in Netherton syndromeKRASAGAKIS, K; IOANNIDOU, D. J; STEPHANIDOU, M et al.Dermatology (Basel). 2003, Vol 207, Num 2, pp 182-184, issn 1018-8665, 3 p.Article

Occupational contact dermatitis due to 2-chloracetophenone tear gasTREUDLER, R; TEBBE, B; BLUME-PEYTAVI, U et al.British journal of dermatology (1951). 1999, Vol 140, Num 3, pp 531-534, issn 0007-0963Conference Paper

Expression of interleukin 10 in human melanomaKRÜGER-KASAGAKES, S; KRASAGAKIS, K; GARBE, C et al.British journal of cancer. 1994, Vol 70, Num 6, pp 1182-1185, issn 0007-0920Article

Differentiation between Merkel cell carcinoma and malignant melanoma : An immunohistochemical studyKONTOCHRISTOPOULOS, G. J; STAVROPOULOS, P. G; KRASAGAKIS, K et al.Dermatology (Basel). 2000, Vol 201, Num 2, pp 123-126, issn 1018-8665Article

Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanomaKRASAGAKIS, K; THÖLKE, D; FARTHMANN, B et al.British journal of cancer. 1998, Vol 77, Num 9, pp 1492-1494, issn 0007-0920Article

Cutaneous mastocytosis in adults: Evaluation of 14 patients with respect to Systemic disease manifestationsTEBBE, B; STAVROPOULOS, P. G; KRASAGAKIS, K et al.Dermatology (Basel). 1998, Vol 197, Num 2, pp 101-108, issn 1018-8665Conference Paper

Merkel cell carcinoma : Report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivityKRASAGAKIS, K; ALMOND-ROESLER, B; ZOUBOULIS, C. C et al.Journal of the American Academy of Dermatology. 1997, Vol 36, Num 5, pp 727-732, issn 0190-9622, 1Article

Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma linesMORRE, D. J; SUN, E; GEILEN, C et al.European journal of cancer (1990). 1996, Vol 32, Num 11, pp 1995-2003, issn 0959-8049Article

Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitroKRASAGAKIS, K; GARBE, C; SCHRIER, P. I et al.Anticancer research. 1994, Vol 14, Num 6B, pp 2565-2571, issn 0250-7005Article